Dr Reddy’s Laboratories (RDY) has released an update.
Dr. Reddy’s Laboratories has announced that its Board of Directors will consider a proposal to sub-divide or split its equity shares, including American Depository Shares, in an upcoming meeting on July 27, 2024. This potential alteration in share capital, aimed at making the stock more accessible to a broader range of investors, is subject to shareholder approval. The company has also informed stakeholders that the trading window for its securities will be closed from June 24 to July 29, 2024.
For further insights into RDY stock, check out TipRanks’ Stock Analysis page.
